Tuesday, January 05, 2010 7:52:30 PM
By Chanyaporn Chanjaroen
Jan. 5 (Bloomberg) -- Copper, which more than doubled last year, is “breaking higher” after passing through a so-called Fibonacci retracement level, according to technical analysis by Dan Smith, an analyst at Standard Chartered Plc.
Copper’s rise above $7,495 a metric ton on the London Metal Exchange yesterday was a 76.4 percent retracement level, and that means $7,760 a ton is “in play now,” Smith wrote in a report. The $7,760 price is the low the metal reached in June 2008, one month before reaching a record $8,940 a ton.
“The break above the previous high suggests we have more room to move upside from here,” London-based Smith said today by phone.
Copper had its best year in at least two decades in 2009 as demand in China, the world’s largest buyer, climbed to a record. Prices have advanced another 1 percent this year after workers went on strike in Chile, the world’s largest copper producing nation.
In technical analysis, investors and analysts study charts of trading patterns and prices to predict changes in a security, commodity, currency or index. Fibonacci analysis is based on the theory that prices rise or fall by certain percentages after reaching a high or low. The $7,495 price was a 76.4 percent retracement of the range between the high of $8,940 in July 2008 and the four-year low of $2,817.25 in December of that year.
Support, or clusters of buying, is at $6,950 a ton for the futures traded on the London Metal Exchange, Smith said. Smith is the most accurate forecaster in the weekly Bloomberg copper survey.
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aqEmpfIQAldY
Recent LQWDF News
- Unlocking Lightening Network Channels With AI • AllPennyStocks.com • 10/05/2023 03:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM